COIOSDeep risk insights through multi-disciplinary research across the globe
Aerial view of a bustling city waterfront with skyscrapers
Item refines Peer-reviewed Added

Distant-stage incidence and cancer mortality trends differ by site across ten US cancers

In US data for 2004-2023, distant-stage incidence rose for breast and prostate cancer and melanoma, while mortality fell.

The study compared distant-stage incidence and cancer-specific mortality trends across ten US solid cancers, 2004-2023, by Joinpoint regression. Of 5,545,600 incident cancers, 1,060,790 were diagnosed at distant stage. Breast and prostate cancer and melanoma had rising distant-stage incidence but falling mortality. Lung and colorectal cancers fell on both measures, while pancreatic, liver and uterine cancers rose on both. All ten paired patterns were unchanged in a common 2004-2019 window. Incidence came from SEER17 registries but mortality was national, so the two measures cover different populations.

Why it is interesting: For breast and prostate cancer, distant-stage incidence and mortality moved in opposite directions. Pancreatic, liver and uterine cancers worsened on both measures over two decades.

Source
JNCI Cancer Spectrum, 17 November 2026
DOI
10.1093/jncics/pkag122
Type
Peer-reviewed article
Design
Registry trend analysis, SEER17 plus national mortality, 5,545,600 incident cancers, 2004-2023, Joinpoint regression
Verdict
Refines prior evidence
Driver
Cancer

Other drivers in Health today